NFKB1 and neoplasm: This implicates PARP1 in both tumour development, by ERK2 stimulation resulting in tumour growth, and in tumour progression, through metastasis by PARP1’s pro-inflammatory effects, as a result of its interaction with the NF-κB pathway [27].